FDA announcementFDA · Drug
Tonight We Ride, LLC Issues Voluntary Recall of Ultimate Forza Male Supplement Due to Presence of Undeclared Sildenafil, Tadalafil, and Dapo
Tonight We Ride, LLC
October 24, 2026, Tonight We Ride, LLC of Lakeville, Minnesota is voluntarily recalling all lots of Ultimate Forza Male Supplement capsules to the consumer level because it has beeโฆ
๐
Oct 24, 2026 ยท ๐ MN
FDA announcementFDA · Drug
Wedgewood Pharmacy Issues Recall of Certain Compounded Veterinary Medications Within Expiry Due to Potential Potency Issues
Wedgewood Pharmacy
SWEDESBORO, N.J., (October 21, 2026) - Wedgewood Pharmacy LLC ("Wedgewood") is recalling certain compounded veterinary medications within expiry at the provider/customer level due โฆ
๐
Oct 21, 2026 ยท ๐ See notice
CLASS II ยท ModerateFDA · Drug
Metoclopramide Tablets
American Health Packaging
Presence of Foreign Tablets/Capsules
๐
Oct 6, 2026 ยท ๐ Nationwide
CLASS II ยท ModerateFDA · Drug
Hydrocortisone Sodium Succinate for Injection
Zydus Pharmaceuticals (USA) Inc
Failed Impurities/Degradation Specifications.
๐
Oct 1, 2026 ยท ๐ Nationwide
CLASS II ยท ModerateFDA · Drug
Metoclopramide Tablets
Teva Pharmaceuticals USA, Inc
Presence of Foreign Tablets/Capsules
๐
Sep 29, 2026 ยท ๐ Nationwide
CLASS II ยท ModerateFDA · Drug
Lidocaine Ointment USP
Preferred Pharmaceuticals, Inc.
Failed Content Uniformity Specifications
๐
Sep 28, 2026 ยท ๐ Nationwide
CLASS III ยท LowFDA · Drug
Tretinoin Cream UPS
SUN PHARMACEUTICAL INDUSTRIES INC
Failed Impurities/Degradation Specifications
๐
Sep 25, 2026 ยท ๐ Nationwide
CLASS III ยท LowFDA · Drug
Tretinoin Cream USP
SUN PHARMACEUTICAL INDUSTRIES INC
Failed Impurities/Degradation Specifications
๐
Sep 25, 2026 ยท ๐ Nationwide
CLASS III ยท LowFDA · Drug
Tretinoin Cream USP
SUN PHARMACEUTICAL INDUSTRIES INC
Failed Impurities/Degradation Specifications
๐
Sep 25, 2026 ยท ๐ Nationwide
CLASS II ยท ModerateFDA · Drug
Clear Eyes Redness Relief
Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company
Lack of Assurance of Sterility
๐
Sep 15, 2026 ยท ๐ Nationwide
CLASS II ยท ModerateFDA · Drug
Clear Eyes Redness Relief
Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company
Lack of Assurance of Sterility
๐
Sep 15, 2026 ยท ๐ Nationwide
CLASS II ยท ModerateFDA · Drug
Sterile High Performance Ultra Lubricating Eye Drops
K.C. Pharmaceuticals, Inc.
Lack of Assurance of Sterility
๐
Sep 11, 2026 ยท ๐ Nationwide
CLASS II ยท ModerateFDA · Drug
Sterile Eye Drops Redness Relief
K.C. Pharmaceuticals, Inc.
Lack of Assurance of Sterility
๐
Sep 11, 2026 ยท ๐ Nationwide
CLASS II ยท ModerateFDA · Drug
Sterile Eye Drops
K.C. Pharmaceuticals, Inc.
Lack of Assurance of Sterility
๐
Sep 11, 2026 ยท ๐ Nationwide
CLASS II ยท ModerateFDA · Drug
Sterile Lubricant Dry Eye Relief Eye Drops
K.C. Pharmaceuticals, Inc.
Lack of Assurance of Sterility
๐
Sep 11, 2026 ยท ๐ Nationwide
CLASS II ยท ModerateFDA · Drug
Eye Drops MAXIMUM
K.C. Pharmaceuticals, Inc.
Lack of Assurance of Sterility
๐
Sep 11, 2026 ยท ๐ Nationwide
CLASS II ยท ModerateFDA · Drug
Sterile EYE DROPS Advanced Relief
K.C. Pharmaceuticals, Inc.
Lack of Assurance of Sterility
๐
Sep 11, 2026 ยท ๐ Nationwide
CLASS II ยท ModerateFDA · Drug
Sterile EYE DROPS AC
K.C. Pharmaceuticals, Inc.
Lack of Assurance of Sterility
๐
Sep 11, 2026 ยท ๐ Nationwide
CLASS II ยท ModerateFDA · Drug
Artificial Tears Sterile Lubricant Eye Drops
K.C. Pharmaceuticals, Inc.
Lack of Assurance of Sterility
๐
Sep 11, 2026 ยท ๐ Nationwide
CLASS II ยท ModerateFDA · Drug
Estradiol Gel
Amneal Pharmaceuticals, LLC
Defective Container; packets were found to be either empty or partially full.
๐
Sep 8, 2026 ยท ๐ Nationwide
CLASS II ยท ModerateFDA · Drug
Chlorthalidone Tablets
Inventia Healthcare Limited
Failed Dissolution Specifications
๐
Sep 3, 2026 ยท ๐ Nationwide
CLASS II ยท ModerateFDA · Drug
Benzoyl Peroxide Wash
SV Labs Toronto Corporation
Microbial contamination of topical product.
๐
Sep 1, 2026 ยท ๐ IL
CLASS II ยท ModerateFDA · Drug
Benzoyl Peroxide Wash
SV Labs Toronto Corporation
Microbial contamination of topical product.
๐
Sep 1, 2026 ยท ๐ IL
CLASS II ยท ModerateFDA · Drug
Lidocaine Ointment USP
SUN PHARMA /TARO
Failed Content Uniformity Specifications. Out of Specification for Assay during analysis at the 24- month long term stability station, at (25ยฟC,60%RH).
๐
Aug 31, 2026 ยท ๐ Nationwide
CLASS III ยท LowFDA · Drug
Trokendi XR
Supernus Pharmaceuticals, Inc.
Failed dissolution specifications.
๐
Aug 31, 2026 ยท ๐ Nationwide
CLASS II ยท ModerateFDA · Drug
Exenatide Injection
Amneal Pharmaceuticals of New York, LLC
Defective Delivery System: Possibility of no medication in the prefilled pen.
๐
Aug 28, 2026 ยท ๐ Nationwide
CLASS III ยท LowFDA · Drug
Olanzapine Tablets
Macleods Pharmaceuticals Limited
Failed Impurities/Degradation Specifications:Organic and unspecified impurities above specification.
๐
Aug 27, 2026 ยท ๐ Nationwide
CLASS II ยท ModerateFDA · Drug
Carton label: Mycophenolate Mofetil for injection
Mylan Pharmaceuticals Inc
Failed Dissolution Specifications
๐
Aug 26, 2026 ยท ๐ Nationwide
CLASS II ยท ModerateFDA · Drug
traZODone Hydrochloride Tablets
Teva Pharmaceuticals USA, Inc
Presence of Foreign Tablets/Capsules
๐
Aug 24, 2026 ยท ๐ Nationwide
CLASS II ยท ModerateFDA · Drug
Ramipril Capsules USP
Hikma Pharmaceuticals USA INC.
Failed Impurities/Degradation Specifications: OOS result obtained for a process impurity, dicyclohexylurea (DCU).
๐
Aug 24, 2026 ยท ๐ Nationwide
CLASS II ยท ModerateFDA · Drug
Prasugrel HCI
Golden State Medical Supply Inc.
Failed Dissolution Specifications. Notification from the manufacturer that lot is being recalled due to failed dissolution
๐
Aug 21, 2026 ยท ๐ Nationwide
CLASS II ยท ModerateFDA · Drug
AvKare Carboxymethylcellulose Sodium Ophthalmic Solution 0.5%
Sterling Pharmaceutical Services LLC
Lack of Assurance of Sterility
๐
Aug 20, 2026 ยท ๐ Nationwide
CLASS II ยท ModerateFDA · Drug
Lubricant Eye Drops-Cameron Pharmaceuticals
Sterling Pharmaceutical Services LLC
Lack of Assurance of Sterility
๐
Aug 20, 2026 ยท ๐ Nationwide
CLASS II ยท ModerateFDA · Drug
Major LubriFresh P.M. Nighttime Ointment
Sterling Pharmaceutical Services LLC
Lack of Assurance of Sterility
๐
Aug 20, 2026 ยท ๐ Nationwide
CLASS II ยท ModerateFDA · Drug
TRP The Relief Products* Gentle Eyes Lubricant Eye Drops
Sterling Pharmaceutical Services LLC
Lack of Assurance of Sterility
๐
Aug 20, 2026 ยท ๐ Nationwide
CLASS II ยท ModerateFDA · Drug
Reliable-1 Laboratories Lubricating Tears
Sterling Pharmaceutical Services LLC
Lack of Assurance of Sterility
๐
Aug 20, 2026 ยท ๐ Nationwide
CLASS II ยท ModerateFDA · Drug
Walgreens Lubricant Eye Drops
Sterling Pharmaceutical Services LLC
Lack of Assurance of Sterility
๐
Aug 20, 2026 ยท ๐ Nationwide
CLASS II ยท ModerateFDA · Drug
Walgreens Lubricant Eye Drops
Sterling Pharmaceutical Services LLC
Lack of Assurance of Sterility
๐
Aug 20, 2026 ยท ๐ Nationwide
CLASS II ยท ModerateFDA · Drug
Reliable -1 Laboratories
Sterling Pharmaceutical Services LLC
Lack of Assurance of Sterility
๐
Aug 20, 2026 ยท ๐ Nationwide
CLASS II ยท ModerateFDA · Drug
AvKare Carboxymethylcellulose Sodium Ophthalmic Solution 0.5%
Sterling Pharmaceutical Services LLC
Lack of Assurance of Sterility
๐
Aug 20, 2026 ยท ๐ Nationwide
CLASS I ยท SeriousFDA · Drug
0.9% Sodium Chloride Injection
B BRAUN MEDICAL INC
Presence of Particulate Matter: particulate matter identified as iron oxide, inorganic material, cellulose cotton fiber or polystyrene
๐
Aug 19, 2026 ยท ๐ Nationwide
CLASS I ยท SeriousFDA · Drug
Dextrose Injection
Baxter Healthcare Corporation
Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution.
๐
Aug 17, 2026 ยท ๐ Nationwide
CLASS I ยท SeriousFDA · Drug
0.9% Sodium Chloride Injection USP 500 mL
Baxter Healthcare Corporation
Presence of particulate matter: Particulates identified as fiberglass
๐
Aug 17, 2026 ยท ๐ See notice
CLASS II ยท ModerateFDA · Drug
Prasugrel Tablets
Mylan Pharmaceuticals Inc
Failed Dissolution Specifications; product failed to meet 18-month stability testing acceptance criteria
๐
Aug 17, 2026 ยท ๐ Nationwide
CLASS I ยท SeriousFDA · Drug
Epinephrine Injection
American Regent, Inc.
Presence of Particulate Matter and Lack of Assurance of Sterility. Particulate matter identified as nylon, cellulosic, acrylic, polyethylene and glass and broken and leaking vials.
๐
Aug 11, 2026 ยท ๐ Nationwide
CLASS II ยท ModerateFDA · Drug
Zicam
Church & Dwight Co., Inc.
CGMP Deviations; FDA inspection of the contract manufacturer noted out of limit results for microbiological testing
๐
Aug 10, 2026 ยท ๐ Nationwide
CLASS II ยท ModerateFDA · Drug
Carbamazepine Tablets
Golden State Medical Supply Inc.
CGMP deviations: tablets with black specks.
๐
Aug 7, 2026 ยท ๐ Nationwide
CLASS II ยท ModerateFDA · Drug
Acthar Gel
Mallinckrodt Hospital Products Inc.
Presence of particulate matter: glass and stopper piece
๐
Aug 6, 2026 ยท ๐ Nationwide
CLASS II ยท ModerateFDA · Drug
Mirabegron Extended-Release Tablets
Zydus Pharmaceuticals (USA) Inc
CGMP: Due to Out of Specification (OOS) result for N-Nitroso Mirabegron impurity.
๐
Aug 5, 2026 ยท ๐ Nationwide
CLASS II ยท ModerateFDA · Drug
Diovan
Novartis Pharmaceuticals Corporation
Failed Dissolution Specifications
๐
Aug 4, 2026 ยท ๐ Nationwide
CLASS II ยท ModerateFDA · Drug
Clobetasol Propionate Cream USP
Lupin Pharmaceuticals Inc.
Failed content uniformity specifications.
๐
Aug 3, 2026 ยท ๐ Nationwide
CLASS II ยท ModerateFDA · Drug
Carbamazepine Tablets
SUN PHARMACEUTICAL INDUSTRIES INC
CGMP Deviations; black spots found on tablets from burnt excipient during manufacturing
๐
Aug 3, 2026 ยท ๐ Nationwide
CLASS I ยท SeriousFDA · Drug
Optiray Imaging Bulk Package-350
Liebel-Flarsheim Company LLC
Presence of Particulate Matter: comprising polyethylene and other plastic materials, stainless steel and glass.
๐
Jul 31, 2026 ยท ๐ Nationwide
CLASS II ยท ModerateFDA · Drug
CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTION
Heritage Pharmaceuticals Inc
Presence of Foreign Substance: presence of particles and white flakes in the reconstituted bottles.
๐
Jul 30, 2026 ยท ๐ Nationwide
CLASS II ยท ModerateFDA · Drug
Libtayo
Regeneron Pharmaceuticals Inc
Lack of Assurance of Sterility
๐
Jul 28, 2026 ยท ๐ Nationwide
CLASS I ยท SeriousFDA · Drug
Cefazolin in Dextrose
Baxter Healthcare Corporation
Presence of Particulate Matter
๐
Jul 24, 2026 ยท ๐ Nationwide
CLASS II ยท ModerateFDA · Drug
Acamprosate Calcium
Mylan Pharmaceuticals Inc
Failed Dissolution Specifications
๐
Jul 24, 2026 ยท ๐ Nationwide
CLASS II ยท ModerateFDA · Drug
Azelaic Acid Gel
Glenmark Pharmaceuticals Inc., USA
CGMP Deviations: Product quality complaints concerning abnormal texture or consistency (described as grainy, gritty, or sandy) were received.
๐
Jul 23, 2026 ยท ๐ Nationwide
CLASS III ยท LowFDA · Drug
Total Parental Nutrition
Central Admixture Pharmacy Services Inc
Incorrect Product Formulation
๐
Jul 16, 2026 ยท ๐ GA
CLASS III ยท LowFDA · Drug
Dabigatran Etexilate Capsules
Ascend Laboratories, LLC
Failed impurity/degradation specification: an OOS result observed in Related substance test analysis w.r.t Impurity II, Impurity III and Total impurities for 12-month stability
๐
Jul 16, 2026 ยท ๐ Nationwide
CLASS III ยท LowFDA · Drug
Dabigatran Etexilate Capsules
Ascend Laboratories, LLC
Failed impurity/degradation specification: an OOS result observed in Related substance test analysis w.r.t Impurity II, Impurity III and Total impurities for 12-month stability
๐
Jul 16, 2026 ยท ๐ Nationwide
CLASS III ยท LowFDA · Drug
Dabigatran Etexilate Capsules
Ascend Laboratories, LLC
Failed impurity/degradation specification: an OOS result observed in Related substance test analysis w.r.t Impurity II, Impurity III and Total impurities for 12-month stability
๐
Jul 16, 2026 ยท ๐ Nationwide
CLASS II ยท ModerateFDA · Drug
Rohto Cooling Eye Drops Cool Relief
Rohto-Mentholatum (Vietnam) Co., Ltd.
Lack of Assurance of Sterility
๐
Jul 14, 2026 ยท ๐ Nationwide
CLASS II ยท ModerateFDA · Drug
Rohto Cooling Eye Drops Dry Aid
Rohto-Mentholatum (Vietnam) Co., Ltd.
Lack of Assurance of Sterility
๐
Jul 14, 2026 ยท ๐ Nationwide
CLASS II ยท ModerateFDA · Drug
Rohto Cooling Eye Drops Dry Aid
Rohto-Mentholatum (Vietnam) Co., Ltd.
Lack of Assurance of Sterility
๐
Jul 14, 2026 ยท ๐ Nationwide
CLASS II ยท ModerateFDA · Drug
Rohto Cooling Eye Drops Digi Eye
Rohto-Mentholatum (Vietnam) Co., Ltd.
Lack of Assurance of Sterility
๐
Jul 14, 2026 ยท ๐ Nationwide
CLASS II ยท ModerateFDA · Drug
Rohto Cooling Eye Drops Optic Glow
Rohto-Mentholatum (Vietnam) Co., Ltd.
Lack of Assurance of Sterility
๐
Jul 14, 2026 ยท ๐ Nationwide
CLASS II ยท ModerateFDA · Drug
Rohto Cooling Eye Drops Max Strength
Rohto-Mentholatum (Vietnam) Co., Ltd.
Lack of Assurance of Sterility
๐
Jul 14, 2026 ยท ๐ Nationwide
CLASS II ยท ModerateFDA · Drug
Rohto Cooling Eye Drops Max Strength
Rohto-Mentholatum (Vietnam) Co., Ltd.
Lack of Assurance of Sterility
๐
Jul 14, 2026 ยท ๐ Nationwide
CLASS II ยท ModerateFDA · Drug
Rohto Cooling Eye Drops ALL-IN-ONE
Rohto-Mentholatum (Vietnam) Co., Ltd.
Lack of Assurance of Sterility
๐
Jul 14, 2026 ยท ๐ Nationwide
CLASS II ยท ModerateFDA · Drug
Rising
Rising Pharma Holding, Inc.
Presence of Precipitate: medication was crystallizing and particles floating in the bottle
๐
Jul 13, 2026 ยท ๐ Nationwide